S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Asian shares slip following technology selloff on Wall Street
66,000% upside on tiny biotech? (Ad)
Tesla: How and Why It Gets To $300
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
66,000% upside on tiny biotech? (Ad)
AI-powered IoT Automation is Driving Samsara To New Highs
What is a Growth Stock Mutual Fund?
66,000% upside on tiny biotech? (Ad)
Persistent inflation, higher interest rates will weigh on global economy, OECD predicts
Sprinklr Gets Targets Raised By Analysts, Here's Why
S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Asian shares slip following technology selloff on Wall Street
66,000% upside on tiny biotech? (Ad)
Tesla: How and Why It Gets To $300
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
66,000% upside on tiny biotech? (Ad)
AI-powered IoT Automation is Driving Samsara To New Highs
What is a Growth Stock Mutual Fund?
66,000% upside on tiny biotech? (Ad)
Persistent inflation, higher interest rates will weigh on global economy, OECD predicts
Sprinklr Gets Targets Raised By Analysts, Here's Why
S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Asian shares slip following technology selloff on Wall Street
66,000% upside on tiny biotech? (Ad)
Tesla: How and Why It Gets To $300
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
66,000% upside on tiny biotech? (Ad)
AI-powered IoT Automation is Driving Samsara To New Highs
What is a Growth Stock Mutual Fund?
66,000% upside on tiny biotech? (Ad)
Persistent inflation, higher interest rates will weigh on global economy, OECD predicts
Sprinklr Gets Targets Raised By Analysts, Here's Why
S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Asian shares slip following technology selloff on Wall Street
66,000% upside on tiny biotech? (Ad)
Tesla: How and Why It Gets To $300
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
66,000% upside on tiny biotech? (Ad)
AI-powered IoT Automation is Driving Samsara To New Highs
What is a Growth Stock Mutual Fund?
66,000% upside on tiny biotech? (Ad)
Persistent inflation, higher interest rates will weigh on global economy, OECD predicts
Sprinklr Gets Targets Raised By Analysts, Here's Why
NYSE:NNVC

NanoViricides (NNVC) Stock Forecast, Price & News

$1.10
-0.03 (-2.65%)
(As of 06/7/2023 ET)
Compare
Today's Range
$1.10
▼
$1.19
50-Day Range
$1.05
▼
$1.63
52-Week Range
$1.04
▼
$3.88
Volume
19,129 shs
Average Volume
37,383 shs
Market Capitalization
$12.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.25
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media

NanoViricides MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
377.3% Upside
$5.25 Price Target
Short Interest
Healthy
2.90% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.75 out of 5 stars

Medical Sector

760th out of 981 stocks

Pharmaceutical Preparations Industry

362nd out of 463 stocks

See Top Rated MarketRank™ Stocks Here

NNVC stock logo

About NanoViricides (NYSE:NNVC) Stock

NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.

Receive NNVC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NanoViricides and its competitors with MarketBeat's FREE daily newsletter.

NNVC Stock News Headlines

June 1, 2023 | americanbankingnews.com
NanoViricides (NYSE:NNVC) Receives New Coverage from Analysts at StockNews.com
May 31, 2023 | finance.yahoo.com
NanoViricides, Inc. to Present at the BIO International Convention in Boston on June 5th, 2023 at 3:15pm ET
June 8, 2023 | Behind the Markets (Ad)
[Strong Buy Alert] Is this laser stock in your portfolio?
🚨 [Strong Buy Alert] Is this laser stock in your portfolio? There are very few opportunities like this in today's bear market... But our analysts identified a tiny defense company landing billions of dollars in contracts every year.
May 23, 2023 | americanbankingnews.com
NanoViricides (NYSEAMERICAN:NNVC) Stock Passes Below 50 Day Moving Average of $1.30
May 19, 2023 | proactiveinvestors.com
Big box retailers lead mixed earnings week as consumers shift focus from goods to experiences
May 16, 2023 | proactiveinvestors.com
NanoViricides ends fiscal 3Q with strong cash runway to begin clinical trials of broad-spectrum COVID drug
May 16, 2023 | finanznachrichten.de
NanoViricides, Inc.: NanoViricides Has Filed its Quarterly Report - Clinical Trials of Broad-Spectrum COVID Drug About to Begin
May 16, 2023 | finance.yahoo.com
NanoViricides Has Filed its Quarterly Report - Clinical Trials of Broad-Spectrum COVID Drug About to Begin
June 8, 2023 | Behind the Markets (Ad)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
May 16, 2023 | americanbankingnews.com
NanoViricides (NYSE:NNVC) Coverage Initiated by Analysts at StockNews.com
May 9, 2023 | americanbankingnews.com
NanoViricides (NYSE:NNVC) Now Covered by StockNews.com
May 4, 2023 | finance.yahoo.com
NanoViricides, Inc. to Present at The Inaugural Ef Hutton Global Conference on May 10, 2023 in New York City
May 2, 2023 | americanbankingnews.com
NanoViricides (NYSE:NNVC) Earns Sell Rating from Analysts at StockNews.com
April 27, 2023 | americanbankingnews.com
StockNews.com Begins Coverage on NanoViricides (NYSE:NNVC)
April 25, 2023 | finance.yahoo.com
NanoViricides is Expanding its Broad-Spectrum Antiviral Program to Explore Further Antiviral Applications of its COVID Clinical Drug Ingredient
April 19, 2023 | msn.com
EF Hutton Reiterates NanoViricides (NNVC) Buy Recommendation
April 19, 2023 | americanbankingnews.com
NanoViricides (NYSE:NNVC) Coverage Initiated at StockNews.com
April 19, 2023 | americanbankingnews.com
StockNews.com Initiates Coverage on NanoViricides (NYSEAMERICAN:NNVC)
April 17, 2023 | finance.yahoo.com
NanoViricides Has Shipped Drug Products for Impending Clinical Trials of NV-CoV-2, Its COVID Drug Candidate
April 12, 2023 | proactiveinvestors.com
NanoViricides using unique technology platform to fight against Viruses
April 10, 2023 | finance.yahoo.com
NNVC: NanoViricides Technology Ready to Enter the Clinic
April 4, 2023 | finance.yahoo.com
NanoViricides Signs a License Agreement That Includes Clinical Evaluation of Its COVID-19 Drug Candidates
January 5, 2023 | finanznachrichten.de
NanoViricides, Inc. to Present at the Biotech Showcase 2023 Conference in San Fransisco on January 9th at 10:30am PT
January 4, 2023 | finance.yahoo.com
NanoViricides, Inc. to Present at the Biotech Showcase(TM) 2023 Conference in San Fransisco on January 9th at 10:30am PT
December 25, 2022 | finance.yahoo.com
NanoViricides, Inc. (NNVC) Stock Historical Prices & Data - Yahoo Finance
December 5, 2022 | finance.yahoo.com
NanoViricides, Inc. to Present at the RHK Capital Disruptive Growth Conference in New York City on December 6th at 1:20pm ET
November 15, 2022 | finanznachrichten.de
Financialnewsmedia.com: Chronic Obstructive Pulmonary Disease (COPD) Market Expected to Reach $25 Billion By 2027
See More Headlines

NNVC Price History

NNVC Company Calendar

Last Earnings
11/15/2021
Today
6/07/2023
Fiscal Year End
6/30/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSE:NNVC
CUSIP
N/A
CIK
1379006
Web
www.nanoviricides.com
Phone
(203) 937-6137
Fax
203-859-5095
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$5.25
High Stock Price Forecast
$5.25
Low Stock Price Forecast
$5.25
Forecasted Upside/Downside
+377.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($0.59)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-8,110,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-32.87%
Return on Assets
-32.19%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
28.46
Quick Ratio
28.46

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.00 per share
Price / Book
0.55

Miscellaneous

Outstanding Shares
11,640,000
Free Float
11,123,000
Market Cap
$12.80 million
Optionable
Optionable
Beta
1.10

Key Executives

  • Anil R. Diwan
    Executive Chairman, President & CEO
  • Meeta R. Vyas
    Chief Financial & Accounting Officer
  • Randall W. Barton
    Chief Scientific Officer
  • Jayant Tatake
    Vice President-Research & Development

Key Competitors

View All Competitors













NNVC Stock - Frequently Asked Questions

Should I buy or sell NanoViricides stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NanoViricides in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" NNVC shares.
View NNVC analyst ratings or view top-rated stocks.

What is NanoViricides' stock price forecast for 2023?

1 Wall Street research analysts have issued 12 month price targets for NanoViricides' stock. Their NNVC share price forecasts range from $5.25 to $5.25. On average, they expect the company's stock price to reach $5.25 in the next twelve months. This suggests a possible upside of 377.3% from the stock's current price.
View analysts price targets for NNVC or view top-rated stocks among Wall Street analysts.

How have NNVC shares performed in 2023?

NanoViricides' stock was trading at $1.11 at the beginning of the year. Since then, NNVC shares have decreased by 0.9% and is now trading at $1.10.
View the best growth stocks for 2023 here.

Are investors shorting NanoViricides?

NanoViricides saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 323,800 shares, a decrease of 21.0% from the April 30th total of 410,100 shares. Based on an average daily volume of 42,400 shares, the short-interest ratio is currently 7.6 days. Currently, 2.9% of the company's stock are sold short.
View NanoViricides' Short Interest.

How were NanoViricides' earnings last quarter?

NanoViricides, Inc. (NYSE:NNVC) announced its quarterly earnings data on Monday, November, 15th. The company reported ($0.23) earnings per share for the quarter, missing analysts' consensus estimates of ($0.20) by $0.03.

When did NanoViricides' stock split?

Shares of NanoViricides reverse split before market open on Tuesday, September 24th 2019. The 1-20 reverse split was announced on Thursday, September 12th 2019. The number of shares owned by shareholders was adjusted after the market closes on Monday, September 23rd 2019. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What is NanoViricides' stock symbol?

NanoViricides trades on the New York Stock Exchange (NYSE) under the ticker symbol "NNVC."

How do I buy shares of NanoViricides?

Shares of NNVC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NanoViricides' stock price today?

One share of NNVC stock can currently be purchased for approximately $1.10.

How much money does NanoViricides make?

NanoViricides (NYSE:NNVC) has a market capitalization of $12.80 million. The company earns $-8,110,000.00 in net income (profit) each year or ($0.59) on an earnings per share basis.

How can I contact NanoViricides?

NanoViricides' mailing address is 1 Controls Drive, Shelton CT, 06484. The official website for the company is www.nanoviricides.com. The company can be reached via phone at (203) 937-6137, via email at clyburn@tradigitalir.com, or via fax at 203-859-5095.

This page (NYSE:NNVC) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -